Skip to main content

Table 3 Dynamic monitoring of serum iPTH, Ca and P levels after PTX procedure

From: Effects of parathyroidectomy on tumoral calcinosis in uremic patients with secondary hyperparathyroidism

Follow-up

Effective group (Group A)

Ineffective group (Group B)

P value

Serum iPTH, pg/ml

2532.8 (1134.0, 2934.9)

629.0 (422.2, 1300.0)

0.101

 7 days

21.5 (7.7, 190.4)

56.0 (43.4, 70.9)

0.79

 3 months

72.0 (50.4, 126.1)

86.0 (65.0, 130.4)

1.00

 6 months

82.7 (58.9, 130.7)

56.5 (45.7, 78.0)

0.25

Serum Calcium, mmol/l

2.3 (2.3, 2.50)

2.2 (2.2, 2.4)

0.26

 7 days

2.2 (2.1, 2.3)

2.0 (1.9, 2.5)

0.65

 3 months

2.0 (1.8, 2.2)

2.3 (2.1, 2.4)

0.25

 6 months

2.0 (1.9, 2.2)

2.1 (2.0, 2.5)

0.393

Average dosage of calcium supplement a

 7 days (g)

13.8 (9.2, 15.0)

2.9 (1.9, 4.7)

0.036

 Serum Phosphate, mmol/l

2.6 (2.4, 2.8)

2.3 (2.2, 2.8)

0.57

 7 days

1.1 (0.9, 1.4)

1.6 (1.4, 1.8)

0.053

 3 months

1.2 (0.7, 1.7)

2.1 (2.0, 2.2)

0.025

 6 months

1.4 (0.9, 1.8)

2.4 (2.3, 3.0)

0.025

  1. Abbreviation: iPTH intact parathyroid hormone, Ca Serum Calcium, P Serum Phosphate, PTX parathyroidectomy
  2. a:Cumulative dose of calcium supplement within 1 week postoperatively, in the form of oral calcium carbonate tablets (40% elemental calcium) and intravenous calcium gluconate (9% elemental calcium)